The skin sensitivity with retatrutide appears to be related to the glucagon receptor component, which is the novel element not present in semaglutide or tirzepatide
However, several studies seem to indicate that Tregs may oppose the progression of diabetic complications by mitigating insulin resistance, atherosclerosis, and damage to target organs (as in kidney disease)
NAD+ taken orally behaves a lot like that: its a fragile, larger molecule that tends to break down in digestion before your cells ever get to use it
Whats important to understand is that pausing or continuing a GLP-1 does not change the bodys need for nourishment
Significant reductions in body weight and improvements in glycaemic control have been demonstrated in early-phase clinical trials, most notably the Phase 2 trial published in the New England Journal of Medicine in 2023 (Jastreboff et al., NEJM 2023)
Even a few quick notes in your phone about nausea levels, energy, and appetite can help you and your provider spot patterns and fine-tune the timing that can help minimize side effects
